| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC1312 |
| Trial ID | NCT00845273 |
| Disease | Macular Degeneration |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Target gene |
| Therapy | Aptamer |
| Treatment | Macugen|pegaptanib|EYE001 |
| Recruitment status | Completed |
| Title | Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan) |
| Year | 2008 |
| Country | United States |
| Company sponsor | Pfizer |
| Other ID(s) | A5751033 |
| Cohort 1 | |||||||||
|
|||||||||